Enwei Pharmaceutical: sign the "Drug Market Licensee (MAH) transfer contract" with Shandong Lono

[Enwei Pharmaceuticals: signed "Drug listing licensee (MAH) transfer contract" with Shandong Lonuo] Enwei Pharmaceutical announced that it signed a "Drug Marketing Licensee (MAH) transfer contract" with Shandong Lonuo, and Shandong Lonuo transferred its developed "acetaminophen ibuprofen tablet" (specification: 250mg/125mg) drug marketing licensee (MAH) and related rights and interests to Enwei Pharmaceutical. The total cost is 26 million yuan.